Heart Disease News and Research

Latest Heart Disease News and Research

Winners of 4th annual Katz Prizes in Cardiovascular Research announced

Columbia University Medical Center today announces the winners of the 4th annual Katz Prizes in Cardiovascular Research, with the senior scientist prize being awarded to an internationally renowned researcher from the National Institutes of Health, and the young investigator prize recognizing a cardiovascular researcher actively studying left ventricular assist devices and heart function.

30 Oct 2009

Case Western Reserve awarded $14.7M to lead study on effects of lowering systolic blood pressure

Case Western Reserve University School of Medicine has received a $14.7 million, nine-year contract from the National Institutes of Health to be one of five institutions to lead a trial to determine if lowering systolic blood pressure in hypertensive patients, without diabetes, to below the currently recommended level can reduce the incidence of cardiovascular and kidney disease and slow cognitive decline.

30 Oct 2009

NIH awards $75 million to establish medical research consortium to combat health disparities

The National Institutes of Health has awarded $75 million to Charles Drew University of Medicine and Science and three other historically black institutions to establish a medical research consortium to combat health disparities in minority and underserved populations.

30 Oct 2009

Official European guidelines for management and treatment of hypertension

A Task Force of the European Society of Hypertension have released the official European guidelines on the management and treatment of hypertension. The guidelines are an update of those published in 2007, and will be published in the November issue of the Journal of Hypertension.

30 Oct 2009

Nonin Medical receives Medical Technology Award for Onyx II, Model 9560

Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, was awarded the Medical Technology Award and its owner and CTO, Phil Isaacson received the Technology Executive of the Year by the Minnesota High Tech Association (MHTA), in partnership with Enterprise Minnesota and LifeScience Alley.

30 Oct 2009

FDA and WebMD Health collaborate to provide increased access to consumer health information

The U.S. Food and Drug Administration and WebMD Health Corp. today announced an expansion of their partnership to provide increased access to FDA's consumer health information.

30 Oct 2009

Thrombolytic therapy can reduce stroke disability if given within the first few hours

Routing stroke patients directly to designated stroke centres - instead of taking them to the nearest hospital - dramatically increased access to a key clot-busting drug that can reduce stroke disability if given within the first few hours of symptoms, researchers report in Stroke: Journal of the American Heart Association.

30 Oct 2009

Study shows how differing Asian cultures and attitudes impact cancer screening rates

The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander."

30 Oct 2009

Majority of consumers say food scoring system would influence their purchasing decisions

Grocery shoppers in a new study report that a one to 100-point food rating system would help them choose what goes into their carts.

30 Oct 2009

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

TomoTherapy Incorporated announced today that several clinical presentations at the American Society for Radiation Oncology's 51st ASTRO Annual Meeting -- November 1-5, 2009 in Chicago -- will showcase the use of the TomoTherapy® radiation therapy platform as a vital component in the combined modality approach to treating cancer.

30 Oct 2009

VIVUS presents additional data on Qnexa Phase 3 trials

VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.

30 Oct 2009

NIH launches randomized trail to determine whether lower BP goal cuts the risk of heart and kidney diseases

The National Institutes of Health is launching a large multicenter randomized clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular and kidney diseases, or age-related cognitive decline.

30 Oct 2009

Aerobics and resistance training exercise prevent visceral fat gain

A study conducted by exercise physiologists in the University of Alabama at Birmingham (UAB) Department of Human Studies finds that as little as 80 minutes a week of aerobic or resistance training helps not only to prevent weight gain, but also to inhibit a regain of harmful visceral fat one year after weight loss.

30 Oct 2009

Celera to use Medical Therapies' midkine patent portfolio for development of novel lung cancer diagnostics

Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY’s midkine patent portfolio for the development of novel lung cancer diagnostics.

30 Oct 2009

Vitamin D deficiency may account for increased risk of end-stage renal disease in African Americans

Low levels of vitamin D may account for nearly 60 percent of the elevated risk of end-stage renal disease (ESRD) in African Americans, according to a report in the December Journal of the American Society of Nephrology (JASN).

30 Oct 2009

Cumberland Pharmaceuticals and Phebra team up to commercialize Caldolor injection

Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.

30 Oct 2009

Also in Global Health news: Sudan food aid; Congolese refugees; Ntds in U.S.

David Deng Athorbei, South Sudan's finance minister, "said he was trying to track down hundreds of millions of dollars worth of missing grain deliveries, at the heart of what could be a massive case of mismanagement or corruption," Reuters reports.

29 Oct 2009

CIRM awards Cedars-Sinai Heart Institute $5.5 million grant for development of cardiac stem cell therapies

A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marb-n, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.

29 Oct 2009

Bolton Medical reports first U.S. trial of its Relay Plus System for endovascular stent-graft procedures

Bolton Medical announced today the first use of its new Relay Plus System in the U.S. Relay Clinical Trial. The case took place at the University of Pennsylvania Medical Center in Philadelphia, PA.

29 Oct 2009

CCS updates the Canadian guidelines for the management and treatment of dyslipidemia

The management of dyslipidemia continues to evolve and despite improvements in recurrent cardiovascular events and a decrease in cardiac mortality, cardiovascular disease (CVD) still represents the major burden of disease in this country.

29 Oct 2009

Heart Disease News and Research

Latest Heart Disease News and Research

Winners of 4th annual Katz Prizes in Cardiovascular Research announced

Case Western Reserve awarded $14.7M to lead study on effects of lowering systolic blood pressure

NIH awards $75 million to establish medical research consortium to combat health disparities

Official European guidelines for management and treatment of hypertension

Nonin Medical receives Medical Technology Award for Onyx II, Model 9560

FDA and WebMD Health collaborate to provide increased access to consumer health information

Thrombolytic therapy can reduce stroke disability if given within the first few hours

Study shows how differing Asian cultures and attitudes impact cancer screening rates

Majority of consumers say food scoring system would influence their purchasing decisions

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

VIVUS presents additional data on Qnexa Phase 3 trials

NIH launches randomized trail to determine whether lower BP goal cuts the risk of heart and kidney diseases

Aerobics and resistance training exercise prevent visceral fat gain

Celera to use Medical Therapies' midkine patent portfolio for development of novel lung cancer diagnostics

Vitamin D deficiency may account for increased risk of end-stage renal disease in African Americans

Cumberland Pharmaceuticals and Phebra team up to commercialize Caldolor injection

Also in Global Health news: Sudan food aid; Congolese refugees; Ntds in U.S.

CIRM awards Cedars-Sinai Heart Institute $5.5 million grant for development of cardiac stem cell therapies

Bolton Medical reports first U.S. trial of its Relay Plus System for endovascular stent-graft procedures

CCS updates the Canadian guidelines for the management and treatment of dyslipidemia

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in